Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: Impact on diagnosis and correlation with grading

Journal of Nuclear Medicine

Volumn 42, Issue 5, 2001, Pages 713-720

  Dimitrakopoulou Strauss, A ^a   Strauss, L G ^a   Schwarzbach, M ^a   Burger, C ^a   Heichel, T ^a   Willeke, F ^a   Mechtersheimer, G ^a   Lehnert, T ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

FDG; Fractal dimension; PET; Sarcomas

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; COMPARTMENT MODEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG UPTAKE; HUMAN; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOFT TISSUE SARCOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; PATHOLOGY; SARCOMA; SCINTISCANNING; SOFT TISSUE TUMOR; TUMOR RECURRENCE;

DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; SARCOMA; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034744063     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)